KLIMKOWSKI CHARLES R 4
4 · BONE CARE INTERNATIONAL INC · Filed Jul 1, 2005
Insider Transaction Report
Form 4
KLIMKOWSKI CHARLES R
Director
Transactions
- Disposition to Issuer
BCII Stock Option Plan
2005-07-01$20.00/sh−12,000$240,000→ 0 totalExercise: $13.00Exp: 2010-12-20→ BCII Common Stock (12,000 underlying) - Disposition to Issuer
BCII Stock Option Plan
2005-07-01$22.75/sh−37,500$853,125→ 0 totalExercise: $10.25Exp: 2009-03-25→ BCII Common Stock (37,500 underlying) - Disposition to Issuer
BCII Stock Option Plan
2005-07-01$24.00/sh−9,000$216,000→ 0 totalExercise: $9.00Exp: 2009-10-12→ BCII Common Stock (9,000 underlying) - Disposition to Issuer
BCII Stock Option Plan
2005-07-01$16.55/sh−10,000$165,500→ 0 totalExercise: $16.45Exp: 2011-12-21→ BCII Common Stock (10,000 underlying) - Disposition to Issuer
BCII Stock Option Plan
2005-07-01$8.90/sh−20,000$178,000→ 0 totalExercise: $24.10Exp: 2014-11-23→ BCII Common Stock (20,000 underlying) - Disposition to Issuer
BCII Common Stock
2005-07-01$33.00/sh−108,500$3,580,500→ 0 total
Footnotes (2)
- [F1]Disposed of pursuant to agreement and plan of merger between issuer and Genzyme Corporation and Macbeth Corporation in exchange for a cash payment of $33.00 per share of BCII Common Stock.
- [F2]Each BCII Stock Option became exercisable in full upon consummation of the merger and was cancelled in the merger and was cancelled in the merger in exchange for a cash payment per share subject to the option equal to the difference between the exercise price of the option and $33.00.